FOXP3 and type 1 diabetes mellitus: To the contrary, the CTB-2.5 mi fusion protein given orally did result in the generation of antigen-specific Foxp3+ CD4 T cells, but treatment did not protect from T1D in our hands, and NOD mice failed to generate oral tolerance against the peptide10.